Future directions and challenges in harnessing NK cells against Acute Myeloid Leukemia

Acute Myeloid Leukemia (AML) remains one of the most challenging hematological malignancies to treat, with relapse and refractory cases continuing to pose significant hurdles

Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC

More than 90% of patients with locally advanced basal cell carcinoma (BCC) of the head and neck achieved locoregional control (LRC) with vismodegib (Erivedge) and

March 2, 2024

CDC: Premature Mortality for Top Causes of Death Higher in Rural Areas

Americans living in rural areas had higher rates of preventable premature mortality from the five leading causes of death than those living in urban areas

May 1, 2024

FDA clears first over-the-counter continuous glucose monitor

For the first time, anyone in the United States will soon be able to buy a continuous glucose monitor without a prescription. The Food and

March 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.